Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers

Piera Rizzolo, Anna Sara Navazio, Valentina Silvestri, Virginia Valentini, Veronica Zelli, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Marco Scarnò, Stefania Tommasi, Domenico Palli, Laura Ottini

Research output: Contribution to journalArticle

Abstract

Male breast cancer (MBC) is a rare disease. Due to its rarity, MBC research and clinical approach are mostly based upon data derived from its largely known female counterpart. We aimed at investigating whether MBC cases harbor somatic alterations of genes known as prognostic biomarkers and molecular therapeutic targets in female breast cancer. We examined 103 MBC cases, all characterized for germ-line BRCA1/2 mutations, for somatic alterations in PIK3CA, EGFR, ESR1 and CCND1 genes. Pathogenic mutations of PIK3CA were detected in 2% of MBCs. No pathogenic mutations were identified in ESR1 and EGFR. Gene copy number variations (CNVs) analysis showed amplification of PIK3CA in 8.1%, EGFR in 6.8% and CCND1 in 16% of MBCs, whereas deletion of ESR1 was detected in 15% of MBCs. Somatic mutations and gene amplification were found only in BRCA1/2 mutation negative MBCs. Significant associations emerged between EGFR amplification and large tumor size (T4), ER-negative and HER2-positive status, between CCND1 amplification and HER2-positive and MIB1-positive status, and between ESR1 deletion and ER-negative status. Our results show that amplification of targetable oncogenes is frequent in BRCA1/2 mutation negative MBCs and may identify MBC subsets characterized by aggressive phenotype that may benefit from potential targeted therapeutic approaches.

Original languageEnglish
Pages (from-to)74097-74106
Number of pages10
JournalOncotarget
Volume7
Issue number45
DOIs
Publication statusPublished - 2016

Keywords

  • Gene copy number variation
  • Germ-line BRCA1/2 mutations
  • Male breast cancer
  • Oncogenes
  • Somatic mutations

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers'. Together they form a unique fingerprint.

  • Cite this

    Rizzolo, P., Navazio, A. S., Silvestri, V., Valentini, V., Zelli, V., Zanna, I., Masala, G., Bianchi, S., Scarnò, M., Tommasi, S., Palli, D., & Ottini, L. (2016). Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers. Oncotarget, 7(45), 74097-74106. https://doi.org/10.18632/oncotarget.12272